Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Checkmate Pharmaceuticals, Inc. CMPI

Set alert

Price alert · CMPI

All alert types
10.50 +10.50 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
231.40M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-4.61
Beta
0.00
Short ratio
0.15
Inst. own
77.51%
Dividend
0.00
Ex-div date
Earnings
May 12, 2022
50-d avg
8.60
200-d avg
4.78
1y target
12.50

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for CMPI has not been loaded yet. Try again in a moment.

Valuation

P/E -1.0×
FY 2018: -5.5×FY 2019: -4.1×FY 2020: -3.8×FY 2021: -1.0×
FY 2018 5y median -3.9× FY 2021
P/S 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2018 5y median 0.0× FY 2021
P/B 0.9×
FY 2018: 12.5×FY 2019: -227×FY 2020: 1.1×FY 2021: 0.9×
FY 2018 5y median 1.0× FY 2021
P/FCF -1.2×
FY 2018: -5.6×FY 2019: -4.3×FY 2020: -3.7×FY 2021: -1.2×
FY 2018 5y median -4.0× FY 2021
EV/EBITDA -0.2×
FY 2018: -5.0×FY 2019: -3.9×FY 2020: -2.6×FY 2021: -0.2×
FY 2018 5y median -3.3× FY 2021
EV/Sales 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2018 5y median 0.0× FY 2021
FCF Yield -86.5%
FY 2018: -17.7%FY 2019: -23.3%FY 2020: -27.3%FY 2021: -86.5%
FY 2018 5y median -25.3% FY 2021

Profitability

Gross Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
Operating Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
Net Margin 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
ROE -88.4%
FY 2018: -226.9%FY 2019: 5569.3%FY 2020: -29.5%FY 2021: -88.4%
FY 2018 5y median -58.9% FY 2021
ROIC -88.4%
FY 2018: -228.9%FY 2019: 5686.8%FY 2020: -29.5%FY 2021: -88.4%
FY 2018 5y median -58.9% FY 2021
ROA -77.9%
FY 2018: -166.6%FY 2019: -551.9%FY 2020: -27.7%FY 2021: -77.9%
FY 2018 5y median -122.2% FY 2021

Growth (YoY)

Revenue 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 FY 2021
Operating Income -66.4%
FY 2018: 0.0%FY 2019: -37.6%FY 2020: -27.7%FY 2021: -66.4%
FY 2018 FY 2021
EPS (diluted) 26.4%
FY 2018: 0.0%FY 2019: -36.0%FY 2020: -12.2%FY 2021: 26.4%
FY 2018 FY 2021
Free Cash Flow -40.9%
FY 2018: 0.0%FY 2019: -31.5%FY 2020: -41.9%FY 2021: -40.9%
FY 2018 FY 2021

Financial Health

Current Ratio 7.9×
FY 2018: 3.8×FY 2019: 0.9×FY 2020: 13.0×FY 2021: 7.9×
FY 2018 5y median 5.8× FY 2021
Quick Ratio 7.9×
FY 2018: 3.8×FY 2019: 0.9×FY 2020: 13.0×FY 2021: 7.9×
FY 2018 5y median 5.8× FY 2021
Debt / Equity 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2018 5y median 0.0× FY 2021
Net Debt / EBITDA 0.8×
FY 2018: 0.6×FY 2019: 0.1×FY 2020: 1.2×FY 2021: 0.8×
FY 2018 5y median 0.7× FY 2021
Interest Coverage 0.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×
FY 2018 5y median 0.0× FY 2021

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%
FY 2018 5y median 0.0% FY 2021

Annual · latest fiscal year ends 2021-12-31